China's Biotech Industry

China's biopharma and biotech sectors are becoming the next EV industry.

Will the next blockbuster drug come from China?​

The biopharma industry is booming following record investment and improved supply chains

Click to expand...

No wonder a lot of fund managers were stocking up on these this year. There's more to come with a lot of IPOs in places like Hong Kong.

Anyway big players include the following:

Jiangsu Hengrui Pharmaceuticals
Innovent Biologics
Akeso
Hansoh Pharmaceutical
Sichuan Biokin Pharmaceutical
Sichuan Kelun-Biotech Biopharmaceutical
Hansoh Pharmaceutical
BeOne Medicines
WuXi AppTec
WuXi Biologics

Severe Fever with Thrombocytopenia Syndrome (SFTS), also known as tick fever, is a relatively new infectious disease that can potentially cause multi-organ failure and result in a fatality rate of up to 30%. It is caused by a tick-borne virus and is transmitted through tick-bites. SFTS mainly occur in central China with some cases reported in Korea and Japan. It was first discovered in 2009. Until recently, there was no specific treatment. Now, Chinese researchers have developed a potential cure.

Chinese scientists develop broad-spectrum nanobodies for tick fever treatment​

Click to expand...

A rationally designed cocktail of nanobodies elicited by heterologous vaccination confers protection against SFTSV in preclinical models​

Click to expand...